oasis 1 oral semaglutide 50 mg nejm 2023 obesity trial Higher-dose oral semaglutide may be beneficial option for type 2 diabetes, obesity Obesity: once-daily oral GLP-1 orforglipron

Researchers found that men have a higher risk of severe COVID-19 infection than women

Foods high in nitric oxide (NO) a molecule involved in healthy, long-lasting erections wont replace ED medications like Viagra ( sildenafil ) and Cialis ( tadalafil )

Tr li: ng vy, vin ung Glutathione 600 c cha cc thnh phn nh sm t n v nhau thai cu, gip ci thin ni tit t n, n nh kinh nguyt v tng cng sinh l

As the New York Times reports, a San Francisco based biopharmaceutical firm called Okava Pharmaceuticals is expected to announce the first pilot study of using these drugs, which are known as GLP-1 agonists, on obese cats

2 This study found that GLP-1 receptor agonist use conferred a lower risk of nonexudative AMD compared to insulin after adjusting for follow-up duration using data from an ophthalmic center